Catalyst Pharmaceuticals Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly and | Outperform |
16
|
$733.51 | $636.99 | 14.18% | 9 | $654.24B |
JNJ | Johnson & Johnson | Outperform |
9
|
$146.14 | $174.55 | 16.33% | 3 | $356.43B |
MRK | Merck | Outperform |
2
|
$131.20 | $130.51 | 8.61% | 11 | $321.69B |
PFE | Pfizer | Outperform |
2
|
$25.40 | $32.87 | 20.08% | 6 | $147.23B |
VRTX | Vertex Pharmaceuticals Inc | Outperform |
12
|
$397.48 | $457.59 | 13.21% | 11 | $101.91B |
REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$883.20 | $961.26 | 18.89% | 8 | $96.37B |
BMY | Bristol-Myers Squibb | Hold |
2
|
$44.85 | $58.15 | 21.52% | 10 | $90.60B |
ZTS | Zoetis | Outperform |
18
|
$158.42 | $220.47 | 39.50% | 5 | $66.94B |
BAX | Baxter International Inc | Outperform |
17
|
$40.13 | $44.86 | 12.14% | 5 | $20.10B |
ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$143.31 | $245.24 | 50.02% | 7 | $18.26B |
VTRS | Viatris Inc | Hold |
8
|
$11.57 | $11.73 | 3.72% | 5 | $13.36B |
UTHR | United Therapeutics | Outperform |
12
|
$233.85 | $284.08 | 27.00% | 3 | $11.20B |
CTLT | Catalent | Hold |
15
|
$55.92 | $49.29 | 13.56% | 3 | $10.04B |
CYTK | Cytokinetics | Outperform |
10
|
$65.34 | $87.92 | 43.86% | 11 | $7.94B |
IONS | Ionis Pharmaceuticals | Outperform |
9
|
$41.59 | $55.60 | 44.75% | 3 | $6.37B |
MDGL | Madrigal Pharmaceuticals | Outperform |
4
|
$193.33 | $315.92 | 101.73% | 5 | $5.01B |
BCPC | Balchem | Outperform |
18
|
$139.26 | $145.00 | 14.53% | 1 | $4.63B |
PRGO | Perrigo Co PLC | Outperform |
16
|
$31.94 | $44.75 | 23.98% | 0 | $4.17B |
NEOG | Neogen | Outperform |
16
|
$12.14 | $37.00 | 40.03% | 0 | $2.51B |
CORT | Corcept Therapeutics | Buy |
16
|
$22.80 | $35.67 | 66.67% | 4 | $2.38B |
INDV | Indivior PLC | Buy |
14
|
£14.08 | £28.89 | 121.88% | 4 | £1.91B |
IRWD | Ironwood Pharmaceuticals | Buy |
14
|
$7.82 | $17.83 | 117.39% | 2 | $2.34B |
TGTX | TG Therapeutics | Outperform |
9
|
$13.47 | $29.44 | 152.41% | 6 | $2.13B |
AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$41.11 | $69.00 | 50.81% | 0 | $1.96B |
SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$30.07 | $41.00 | 33.02% | 0 | $1.61B |
LGND | Ligand Pharmaceuticals | Outperform |
14
|
$70.57 | $111.83 | 55.87% | 3 | $1.56B |
ANIP | ANI Pharmaceuticals | Buy |
13
|
$65.36 | $69.75 | 22.40% | 1 | $1.37B |
ARPO | Aerpio Pharmaceuticals | - |
6
|
$30.30 | $330.00 | 15.51% | 0 | $1.24B |
PCRX | Pacira BioSciences | Outperform |
16
|
$26.33 | $47.90 | 70.91% | 6 | $1.22B |
COLL | Collegium Pharmaceutical | Outperform |
11
|
$36.42 | $37.75 | 9.83% | 1 | $1.14B |
ATRS | Antares Pharma | - |
8
|
$5.59 | $5.60 | 16.46% | 0 | $955.07M |
USNA | USANA Health Sciences | Hold |
14
|
$43.47 | $104.00 | 29.97% | 1 | $836.39M |
INVA | Innoviva | Hold |
16
|
$15.26 | $15.00 | -1.70% | 1 | $947.78M |
SAVA | Cassava Sciences | Outperform |
8
|
$22.34 | $124.00 | 455.06% | 1 | $857.59M |
BSTC | BioSpecifics Technologies | - |
14
|
$0.00 | $88.50 | 0.00% | 0 | $647.97M |
BDSI | BioDelivery Sciences Internati... | - |
11
|
$5.59 | $10.00 | 16.46% | 0 | $577.05M |
ESPR | Esperion Therapeutics | Outperform |
10
|
$1.90 | $8.19 | 321.05% | 1 | $494.21M |
HROW | Harrow | Buy |
12
|
$10.53 | $28.13 | 156.41% | 1 | $389.81M |
ADMS | Adamas Pharmaceuticals | - |
7
|
$8.22 | $8.52 | -100.00% | 3 | $376.37M |
AERI | Aerie Pharmaceuticals | - |
7
|
$0.73 | $15.25 | -100.00% | 0 | $358.35M |
NATR | Nature's Sunshine Products | Buy |
16
|
$19.50 | $21.50 | 23.08% | 1 | $340.49M |
RIGL | Rigel Pharmaceuticals | Outperform |
4
|
$1.10 | $4.04 | 127.27% | 3 | $258.07M |
ZVRA | Zevra Therapeutics | Buy |
10
|
$4.52 | $19.50 | 309.29% | 1 | $253.06M |
RCEL | AVITA Medical | Buy |
6
|
$8.52 | $37.39 | 350.70% | 6 | $222.91M |
ATOS | Atossa Genetics Inc | Buy |
5
|
$1.53 | $4.83 | 161.44% | 0 | $219.28M |
AVM | AMAG Pharmaceuticals | - |
2
|
$314.00 | $13.75 | -100.00% | 0 | $211.76M |
ALIM | Alimera Sciences | Buy |
9
|
$3.49 | $7.00 | 129.23% | 3 | $185.33M |
NKTR | Nektar Therapeutics | Hold |
11
|
$1.32 | $2.75 | -24.24% | 2 | $171.69M |
PRTK | Paratek Pharmaceuticals | - |
2
|
$2.21 | $2.15 | -100.00% | 2 | $143.19M |
KPTI | Karyopharm Therapeutics | Outperform |
6
|
$1.06 | $6.00 | 371.70% | 1 | $134.63M |
CTXR | Citius Pharmaceuticals | Outperform |
4
|
$0.66 | $3.17 | 506.06% | 0 | $133.90M |
SCTL | Societal CDMO | Hold |
9
|
$1.10 | $1.86 | 0.00% | 1 | $116.26M |
AGEN | Agenus | Buy |
8
|
$11.69 | $6.67 | 584.35% | 2 | $111.22M |
GALT | Galectin Therapeutics | Outperform |
6
|
$1.74 | $11.00 | 532.18% | 0 | $102.05M |
SNSS | Sunesis Pharmaceuticals | - |
2
|
$0.00 | $42.00 | 0.00% | 0 | $96.26M |
ASRT | Assertio Holdings | Buy |
8
|
$0.83 | $3.50 | 261.45% | 2 | $88.49M |
LFVN | LifeVantage |
0
|
$6.19 | $7.00 | -100.00% | 0 | $86.22M | |
CBLI | Cleveland BioLabs | - |
4
|
$3.42 | $40.00 | -100.00% | 0 | $84.62M |
EGRX | Eagle Pharmaceuticals | - |
14
|
$4.16 | $17.00 | -100.00% | 0 | $84.16M |
AKN | Akorn Operating Company LLC | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $70.85M |
OPNT | Opiant Pharmaceuticals | - |
10
|
$20.77 | $21.00 | -100.00% | 0 | $63.99M |
MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.18 | $0.65 | 455.56% | 0 | $56.27M |
FBIO | Fortress Biotech | Buy |
11
|
$1.72 | $67.50 | 336.05% | 1 | $33.66M |
IGC | IGC Pharma | Buy |
4
|
$0.46 | $3.05 | 606.52% | 0 | $32.37M |
NBEV.Q | NewAge | - |
6
|
$0.00 | $3.50 | 0.00% | 0 | $29.73M |
DRRX | DURECT | Outperform |
9
|
$0.93 | $6.75 | 625.81% | 2 | $28.93M |
DARE | Daré Bioscience | Outperform |
5
|
$0.31 | $4.00 | 1190.32% | 1 | $28.16M |
TXMD | TherapeuticsMD | - |
5
|
$2.26 | $5.00 | 3.10% | 0 | $27.14M |
ACER | Acer Therapeutics | - |
0
|
$0.66 | $12.00 | -100.00% | 0 | $23.28M |
LCI | Lannett Company | - |
10
|
$0.03 | $4.00 | -100.00% | 1 | $21.85M |
MEIP | MEI Pharma | Outperform |
10
|
$3.05 | $23.33 | 555.74% | 1 | $21.65M |
ACRX | AcelRx Pharmaceuticals | Buy |
6
|
$1.05 | $4.63 | 388.57% | 0 | $21.53M |
JAGX | Jaguar Health | - |
0
|
$0.08 | $5.88 | -50.00% | 0 | $17.40M |
COCP | Cocrystal Pharma | Buy |
0
|
$1.56 | $8.33 | 541.03% | 1 | $15.67M |
LPCN | Lipocine | Buy |
2
|
$4.01 | $36.33 | 810.22% | 0 | $13.24M |
CNSP | CNS Pharmaceuticals | - |
0
|
$0.29 | $6.25 | -44.83% | 0 | $11.81M |
MYOS | MYOS RENS Technology | - |
0
|
$0.00 | $45.00 | 0.00% | 0 | $11.56M |
GHSI | Guardion Health Sciences | Hold |
0
|
$7.90 | $12.00 | -100.00% | 1 | $10.26M |
TOVX | Theriva Biologics | Buy |
2
|
$0.42 | $4.50 | 971.43% | 1 | $8.43M |
ADIL | Adial Pharmaceuticals | Outperform |
0
|
$1.61 | $17.00 | 365.84% | 2 | $7.83M |
AVTX | Avalo Therapeutics | Hold |
0
|
$4.46 | $0.00 | -45.29% | 0 | $7.79M |
SNGX | Soligenix | Buy |
6
|
$0.42 | $3.25 | 733.33% | 0 | $7.56M |
ATXI | Avenue Therapeutics | Buy |
-7
|
$6.20 | $16.38 | 19708.55% | 0 | $5.50M |
KPRX | Kiora Pharmaceuticals | Outperform |
11
|
$0.47 | $12.83 | 538.30% | 2 | $4.86M |
FRTX | Fresh Tracks Therapeutics | - |
-8
|
$0.99 | $0.00 | -100.00% | 0 | $4.59M |
EVOK | Evoke Pharma | Outperform |
6
|
$0.46 | $7.00 | 1421.74% | 1 | $3.97M |
ARTL | Artelo Biosciences | Outperform |
-14
|
$1.67 | $0.00 | 199.40% | 0 | $3.88M |
AGRX | Agile Therapeutics | - |
7
|
$0.40 | $8.50 | -100.00% | 0 | $2.61M |
NBY | NovaBay Pharmaceuticals | Buy |
-9
|
$0.08 | $3.65 | 3150.00% | 1 | $2.48M |
VVUS.Q | VIVUS | - |
0
|
$0.00 | $2.50 | 0.00% | 0 | $2.26M |
YCBD | cbdMD | Outperform |
0
|
$0.87 | $3.00 | 129.89% | 1 | $2.13M |
AMPE | Ampio Pharmaceuticals | - |
0
|
$1.71 | $0.00 | -100.00% | 0 | $1.76M |
EVFM | Evofem Biosciences | Hold |
0
|
$0.02 | $225.00 | -100.00% | 1 | $0.83M |
ZSAN.Q | Zosano Pharma | - |
6
|
$0.00 | $1.00 | 0.00% | 0 | $0.50M |
DMK | DMK Pharmaceuticals | - |
8
|
$0.04 | $1.50 | -100.00% | 0 | $0.35M |
IG | Teligent | - |
2
|
$0.00 | $1.00 | 0.00% | 0 | $0.02M |
TMBR.Q | Timber Pharmaceuticals | - |
0
|
$0.00 | $11.00 | 0.00% | 0 | $0.00M |
FLXN | Flexion Therapeutics | - |
0
|
$9.25 | $10.00 | -100.00% | 0 | $0.00M |
ZGNX | Zogenix | - |
0
|
$0.00 | $27.00 | 0.00% | 0 | $0.00M |
INFI.Q | Infinity Pharmaceuticals | - |
7
|
$0.00 | $0.30 | 0.00% | 1 | $0.00M |